Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography
- Conditions
- Heart Failure, DiastolicEchocardiography
- Registration Number
- NCT05768698
- Lead Sponsor
- Istituto Auxologico Italiano
- Brief Summary
The goal of this single-center, prospective, observational study is to validate a software package based on an artificial intelligence algorithm for automated non-invasive estimation of LVFP against invasively measured ones by left and right heart catheterization; In addition, the added value of this new automated software to detect increased LVEDP \> 15 mm Hg compared to the current ASE/EACVI algorithm for assessing diastolic dysfunction and longitudinal left atrial strain during the reservoir phase will be evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- ≥ 18 yo,
- Signed informed consent to be part of this study,
- No pregnancy,
- Good acoustic window and patient cooperation to obtain good 2- and 3-dimensional datasets focused on left atrium (LA),
- Unwillingness to be part of the study,
- Patients with poor 2-dimensional imaging quality in ≥ 1 LA segment or lacking of a discernible R-R interval, which might preclude accurate strain measurements,
- Patients with more than mild mitral valve heart disease, aortic regurgitation, left side valvular prosthesis or mitral valve repair, mitral annulus calcification (≥ 5 mm),
- Patients with history or presence of atrial fibrillation (AF), supraventricular arrhythmias, ventricular paced rhythm, left bundle branch block (LBBB),
- Patients taking diuretics or vasodilators (nitrates) on the day of the examination, which could alter loading conditions.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Left ventricular filling pressure During procedure Invasively measured left ventricular filling pressure by right heart catheterization
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Philips Healthcare
🇺🇸Andover, Massachusetts, United States